Study S000709

Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02109315
Acronym: DIAB-01
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2014-05
Primary completion: 2015-05
Lead sponsor: Anna Cruceta
Conditions: Type 1 Diabetes Mellitus
Interventions: DRUG:Vitamine C; DRUG:Liraglutide 6 mg
Results posted: FALSE

Registered primary outcomes

Endothelial dysfunction (Flow mediated dilation): Endothelial function is assessed measuring flow-mediated vasodilation (FMD) of the brachial artery. [8 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.